The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.

about

The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.

Item

http://www.wikidata.org/entity/Q48226512

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The polymethoxy flavonoid suda ...... tion in osteoclast precursors.

@en

The polymethoxy flavonoid suda ...... tion in osteoclast precursors.

@nl

type

Item

label

The polymethoxy flavonoid suda ...... tion in osteoclast precursors.

@en

The polymethoxy flavonoid suda ...... tion in osteoclast precursors.

@nl

prefLabel

The polymethoxy flavonoid suda ...... tion in osteoclast precursors.

@en

The polymethoxy flavonoid suda ...... tion in osteoclast precursors.

@nl

P1476

The polymethoxy flavonoid suda ...... ation in osteoclast precursors

@en

P2093

Jun Shimada

http://www.w3.org/2001/XMLSchema#string

Junta Ito

http://www.w3.org/2001/XMLSchema#string

Victor J Kitano

http://www.w3.org/2001/XMLSchema#string

Yoko Ohyama

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Osteoclasts: what do they do and how do they do it?

Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice

Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system

DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells

A new superoxide-generating oxidase in murine osteoclasts

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

P304

e0191192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0191192

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoshiyuki Hakeda

P577

2018-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29342179

http://www.w3.org/2001/XMLSchema#string

P932

5771597

http://www.w3.org/2001/XMLSchema#string